Short Interest in Nanobiotix S.A. (NASDAQ:NBTX) Grows By 850.6%

Nanobiotix S.A. (NASDAQ:NBTXGet Rating) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 73,200 shares, an increase of 850.6% from the April 30th total of 7,700 shares. Approximately 0.2% of the shares of the company are short sold. Based on an average daily volume of 673,100 shares, the short-interest ratio is currently 0.1 days.

Nanobiotix Stock Down 0.2 %

Nanobiotix stock traded down $0.01 during mid-day trading on Friday, hitting $4.82. 17,406 shares of the company’s stock traded hands, compared to its average volume of 585,089. The firm has a 50 day moving average price of $3.90 and a 200 day moving average price of $3.89. Nanobiotix has a one year low of $1.75 and a one year high of $7.76.

About Nanobiotix

(Get Rating)

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.

See Also

Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with's FREE daily email newsletter.